Evaluating Tumor Quantification in Place of Proportions in Prostate Cancer: Principles of the ProQuant Group.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 41419390.
- Also identified by DOI 10.1016/j.eururo.2025.11.013.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We describe the rationale for using quantification of Gleason pattern 4 rather than the proportion of Gleason patterns for risk stratification in prostate cancer, as proposed by the ProQuant Group. We outline research that will be conducted to assess this strategy, and invite individuals interested in collaboration to join the group.
Medical subject headings
- Prostatic Neoplasms